Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme
Class IITerminatedD-0653-2022

Drug recall · March 23, 2022

hydrALAZINE HCl Tablets recall

Why: Failed Impurities/Degradation Specifications: Out of specification result obtained during routine stability testing for Impurities.

Class II: could cause temporary or reversible health problems; serious harm is remote.

The recall

Product

hydrALAZINE HCl Tablets, USP, 10 mg, 100 Tablets per carton (10x10 blister packs), Rx only, Distributed by: MAJOR PHARMACEUTICALS, Livonia, MI 48152 USA. NDC # 0904-6440-61

Lots / codes

Lot #: T03755, T03756, Exp. Date 03/2023

Quantity
5,953 cartons
Company
The Harvard Drug Group, Livonia, MI
Distribution
Nationwide within USA
Initiated
February 24, 2022 · Voluntary: Firm initiated
Classified
March 14, 2022
Reported
March 23, 2022
Ended
July 16, 2023
How notified
Letter

The drug: prices, other makers, shortages

If you have this product

  1. Check the lot number on your package against the lots above. Only those lots are recalled.
  2. Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
  3. Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
  4. Return or dispose of recalled product as the company or your pharmacy advises.

Questions about this recall

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Watch Hydralazine

One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.